Status:
RECRUITING
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
Lead Sponsor:
Marshall University
Conditions:
Systolic Hypertension
Pregnancy Related
Eligibility:
FEMALE
18-45 years
Brief Summary
The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynam...
Detailed Description
When a patient presents to the Maternal Hypertension Center at Cabell Huntington Hospital, she will receive a non-invasive hemodynamic assessment via the NICaS system as per usual protocol. The NICaS ...
Eligibility Criteria
Inclusion
- Patients presenting to Maternal Hypertension Center at Cabell Huntington Hospital
- English speaking
- 18-45 years old.
- Willing to provide informed consent
- Gestational age prior to 15 weeks gestation
Exclusion
- Non-English speaking patients, patients
- \<18 years old or \>45 years old
- Not willing or able to provide consent
- Gestational age \>15 weeks
Key Trial Info
Start Date :
March 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04755764
Start Date
March 3 2021
End Date
December 1 2025
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternal Hypertension Center at Cabell Huntington Hospital
Huntington, West Virginia, United States, 25701